{"cdcTestId":"2013-0511","testcaseName":"# 1 at age 16 years -4 days","vaccineGroup":"MCV","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2006-10-23T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"meningococcal MCV4, unspecified formulation","cvx":"147","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"meningococcal MCV4, unspecified formulation","cvx":"147","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-01T12:23:05.951","generalDescription":"This test case describes when a dose of a Mening vaccine is administered at 16 years - 4 days, that the dose is considered to be valid. The series is complete.","changedInVersion":"1.0","reasonForChange":""}